CIK 0001374690 · Non-accelerated filer<br>Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203857670
- Phone
- 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $382,086
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$382,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-31 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2023-01-31 | BEN-MAIMON CAROLE President and CEO | Grant or award | +205,000 | 261,829 | ||
| 2023-01-31 | BEN-MAIMON CAROLE President and CEO | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2022-09-16 | Flynn James E Director | Purchase | +2,777,777 | $3.15 | $8.7M | 4,721,183 |
| 2022-09-16 | Flynn James E Director | Purchase | +2,777,777 | $3.15 | $8.7M | 4,721,200 |
| 2022-09-16 | Flynn James E Director | Purchase | +2,777,777 | $3.15 | $8.7M | 4,721,197 |
| 2022-09-16 | Flynn James E Director | Purchase | +2,777,777 | $3.15 | $8.7M | 2,777,777 |
| 2022-09-16 | Hamilton Thomas Edward Director | Purchase | +317,460 | $3.15 | $1000K | 507,590 |
| 2022-09-16 | Celano Michael Chief Financial Officer | Purchase | +31,746 | $3.15 | $100K | 31,746 |
| 2022-09-16 | BEN-MAIMON CAROLE President and CEO | Purchase | +31,746 | $3.15 | $100K | 56,829 |
| 2022-05-10 | BEN-MAIMON CAROLE President and CEO | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-05-10 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2022-05-10 | Truitt Joseph Director | Grant or award · Stock Option (Right to Buy) | +8,300 | 8,300 | ||
| 2022-05-10 | Barrett Peter Director | Grant or award · Stock Option (Right to Buy) | +8,300 | 8,300 | ||
| 2022-05-10 | Hamilton Thomas Edward Director | Grant or award · Stock Option (Right to Buy) | +8,300 | 8,300 | ||
| 2022-05-10 | LEFF JONATHAN S Director | Grant or award · Stock Option (Right to Buy) | +8,300 | 8,300 | ||
| 2022-05-10 | THOMAS FRANK E Director | Grant or award · Stock Option (Right to Buy) | +8,300 | 8,300 | ||
| 2022-05-10 | Flynn James E Director | Grant or award · Stock Option (Right to Buy) | +8,300 | 8,300 | ||
| 2022-01-18 | Celano Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-01-18 | BEN-MAIMON CAROLE President and CEO | Grant or award · Stock Option (Right to Buy) | +182,000 | 182,000 |
Page 5 of 7 · 136 trades